COVID-19 pandemic affecting industries across the globe. The coronavirus outbreak has started to hit India’s pharmaceutical sector by raising the prices of key ingredients. COVID-19 is a very dynamic situation. We believe there would be indirect effects on the continuity of supply of medicines due to lockouts, manpower supply, raw materials supply issue, stoppage of transportation, etc.
Moreover, in a time of economic regression and global health fears due to Covid-19, the reputations of pharmaceutical companies are on the line and their impact on the fight against the virus will not be easily forgotten. The concept of large profits coming from newly developed drugs will face increased scrutiny in a time of global pandemic as a result of public and competitive pressures.